StockNews.com Initiates Coverage on Enzo Biochem (NYSE:ENZ)

Research analysts at StockNews.com assumed coverage on shares of Enzo Biochem (NYSE:ENZ) in a report issued on Friday. The firm set a “hold” rating on the medical research company’s stock.

Enzo Biochem Stock Down 3.1 %

ENZ stock opened at $0.46 on Friday. The business has a 50 day moving average of $0.60 and a 200-day moving average of $0.90. Enzo Biochem has a 12-month low of $0.41 and a 12-month high of $1.32.

Enzo Biochem (NYSE:ENZ) last released its quarterly earnings results on Monday, December 16th. The medical research company reported ($0.05) EPS for the quarter. Enzo Biochem had a negative net margin of 75.34% and a negative return on equity of 7.96%.

Institutional Trading of Enzo Biochem

Several large investors have recently added to or reduced their stakes in ENZ. Virtu Financial LLC purchased a new stake in shares of Enzo Biochem in the 4th quarter worth about $35,000. Lepercq Multi Asset Fund bought a new position in Enzo Biochem in the fourth quarter worth about $88,000. BBR Partners LLC purchased a new stake in Enzo Biochem in the third quarter worth about $112,000. Wittenberg Investment Management Inc. boosted its position in Enzo Biochem by 60.1% during the 4th quarter. Wittenberg Investment Management Inc. now owns 187,537 shares of the medical research company’s stock valued at $134,000 after acquiring an additional 70,400 shares in the last quarter. Finally, Geode Capital Management LLC grew its holdings in shares of Enzo Biochem by 3.3% during the 3rd quarter. Geode Capital Management LLC now owns 368,646 shares of the medical research company’s stock worth $413,000 after acquiring an additional 11,742 shares during the period. Institutional investors own 36.90% of the company’s stock.

Enzo Biochem Company Profile

Enzo Biochem, Inc develops, manufactures, and markets products and tools for clinical research, translational research, drug development, and bioscience research customers worldwide. The company offers proteins, antibodies, peptides, small molecules, labeling probes, dyes, and kits, which provide life science researchers tools for target identification/validation, content analysis, gene expression analysis, nucleic acid detection, protein biochemistry and detection, and cellular analysis.